Skip to main content
. 2020 Jul 28;12(16):16224–16237. doi: 10.18632/aging.103644

Figure 2.

Figure 2

Overexpression of SirT3 or activation of AMPK attenuates LPS-mediated cardiomyocyte dysfunction. (AF) Cardiomyocyte contractility in response to LPS treatment. Lentivirus-loaded SirT3 (SirT3-OE) and AMPK agonist (AICAR) were incubated with cardiomyocyte in the presence of LPS. +dL/dt is the maximal velocity of shortening. −dL/dt is the maximal velocity of relengthening. TPS, time to peak shortening; TR90, time to 90% relengthening. *P < 0.05.